These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 30837588)
21. Effects of conformational alteration induced by D-/L-isonucleoside incorporation in siRNA on their stability in serum and silencing activity. Huang Y; Chen Z; Chen Y; Zhang H; Zhang Y; Zhao Y; Yang Z; Zhang L Bioconjug Chem; 2013 Jun; 24(6):951-9. PubMed ID: 23682837 [TBL] [Abstract][Full Text] [Related]
22. Introduction and History of the Chemistry of Nucleic Acids Therapeutics. Gait MJ; Agrawal S Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007 [TBL] [Abstract][Full Text] [Related]
23. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts. Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810 [TBL] [Abstract][Full Text] [Related]
24. Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras. Subramanian N; Kanwar JR; Kanwar RK; Krishnakumar S Nucleic Acid Ther; 2015 Dec; 25(6):317-22. PubMed ID: 26334953 [TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics simulation and binding energy calculation for estimation of oligonucleotide duplex thermostability in RNA-based therapeutics. Shen L; Johnson TL; Clugston S; Huang H; Butenhof KJ; Stanton RV J Chem Inf Model; 2011 Aug; 51(8):1957-65. PubMed ID: 21702481 [TBL] [Abstract][Full Text] [Related]